Literature DB >> 14663128

Diagnosis of pelvic inflammatory disease: time for a rethink.

I Simms1, F Warburton, L Weström.   

Abstract

OBJECTIVES: To critically evaluate the available evidence base concerned with the diagnosis of pelvic inflammatory disease (PID) based on clinical presentation, and to investigate the relation between signs and symptoms and the presence of laparoscopically diagnosed PID using the largest available dataset.
METHODS: The evidence base was critically evaluated and data collected by Lund University between 1960 and 1969 were used to compare clinical presentation with the results of laparoscopic investigation. Three techniques were used in this investigation-sensitivity and specificity, likelihood ratios, and discriminant analysis.
RESULTS: None of the variables (abnormal vaginal discharge, fever >38 degrees C, vomiting, menstrual irregularity, ongoing bleeding, symptoms of urethritis, rectal temperature >38 degrees C, marked tenderness of pelvic organs on bimanual examination, adnexal mass, and erythrocyte sedimentation rate >or=15 mm in the first hour) had both high specificity and sensitivity-most had low specificity and sensitivity. There was little variation in either the likelihood ratios or the post-test probabilities between the variables. The lowest likelihood ratio (0.97) produced a post-test probability of 78% (95% CI: 74% to 81%) whereas the highest (1.73) had a post-test probability of 84% (95% CI: 81% to 87%). The pretest probability of having PID based on the presence of lower abdominal pain was 79% (95% CI: 76% to 82%). The discriminant analysis indicated that three variables significantly influenced the prediction of the presence of PID: erythrocyte sedimentation rate (p<0.0001), fever (p<0.0001), and adnexal tenderness (p<0.0001). These variables correctly classified 65% of patients with laparoscopically diagnosed PID (95% CI: 61% to 69%).
CONCLUSION: There is insufficient evidence to support existing diagnostic criteria, which have been based on a combination of empirical data and expert opinion. A new evidence base is urgently needed but this will require either a new investigation of the association between clinical presentation and PID based on a laparoscopic "gold standard" or the development of new diagnostic techniques.

Entities:  

Mesh:

Year:  2003        PMID: 14663128      PMCID: PMC1744780          DOI: 10.1136/sti.79.6.491

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  15 in total

Review 1.  Pelvic inflammatory disease.

Authors:  J Ross
Journal:  BMJ       Date:  2001-03-17

Review 2.  Pelvic inflammatory disease--an evidence-based approach to diagnosis.

Authors:  P E Munday
Journal:  J Infect       Date:  2000-01       Impact factor: 6.072

Review 3.  Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model.

Authors:  J G Kahn; C K Walker; A E Washington; D V Landers; R L Sweet
Journal:  JAMA       Date:  1991-11-13       Impact factor: 56.272

4.  Serum C-reactive protein determination in acute pelvic inflammatory disease.

Authors:  M Lehtinen; S Laine; P K Heinonen; K Teisala; A Miettinen; R Aine; R Punnonen; P Grönroos; J Paavonen
Journal:  Am J Obstet Gynecol       Date:  1986-01       Impact factor: 8.661

5.  Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy.

Authors:  L Jacobson; L Weström
Journal:  Am J Obstet Gynecol       Date:  1969-12-01       Impact factor: 8.661

6.  Criteria for diagnosis and grading of salpingitis.

Authors:  W D Hager; D A Eschenbach; M R Spence; R L Sweet
Journal:  Obstet Gynecol       Date:  1983-01       Impact factor: 7.661

7.  Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin.

Authors:  J N Wasserheit; T A Bell; N B Kiviat; P Wølner-Hanssen; V Zabriskie; B D Kirby; E C Prince; K K Holmes; W E Stamm; D A Eschenbach
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

8.  Serum CA 125 in acute pelvic inflammatory disease.

Authors:  J Paavonen; A Miettinen; P K Heinonen; R K Aaran; K Teisala; R Aine; R Punnonen; S Laine; O P Kallioniemi; M Lehtinen
Journal:  Br J Obstet Gynaecol       Date:  1989-05

9.  Screening for Chlamydia trachomatis. New methods are needed to assess the burden of illness from chlamydia.

Authors:  I Simms; G Hughes; M Catchpole
Journal:  BMJ       Date:  1998-09-05

10.  Predicting acute pelvic inflammatory disease: a multivariate analysis.

Authors:  A Hadgu; L Westrom; C A Brooks; G H Reynolds; S E Thompson
Journal:  Am J Obstet Gynecol       Date:  1986-11       Impact factor: 8.661

View more
  13 in total

1.  Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study.

Authors:  N Low; M Egger; J A C Sterne; R M Harbord; F Ibrahim; B Lindblom; B Herrmann
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

2.  RNA Biosignatures in Adolescent Patients in a Pediatric Emergency Department With Pelvic Inflammatory Disease.

Authors:  Fran Balamuth; Zhe Zhang; Eric Rappaport; Katie Hayes; Cynthia Mollen; Kathleen E Sullivan
Journal:  Pediatr Emerg Care       Date:  2015-07       Impact factor: 1.454

3.  The role of speculum and bimanual examinations when evaluating attendees at a sexually transmitted diseases clinic.

Authors:  Rameet H Singh; Emily J Erbelding; Jonathan M Zenilman; Khalil G Ghanem
Journal:  Sex Transm Infect       Date:  2006-11-15       Impact factor: 3.519

4.  Simultaneous detection of seven sexually transmitted agents in human immunodeficiency virus-infected Brazilian women by multiplex polymerase chain reaction.

Authors:  Raquel P Souza; André L P de Abreu; Érika C Ferreira; Sheila C Rocha-Brischiliari; Maria D de B Carvalho; Sandra M Pelloso; Marcelo G Bonini; Fabrícia Gimenes; Marcia E L Consolaro
Journal:  Am J Trop Med Hyg       Date:  2013-09-30       Impact factor: 2.345

Review 5.  Improving adherence to guidelines for the diagnosis and management of pelvic inflammatory disease: a systematic review.

Authors:  Bette Liu; Basil Donovan; Jane S Hocking; Janet Knox; Bronwyn Silver; Rebecca Guy
Journal:  Infect Dis Obstet Gynecol       Date:  2012-08-29

6.  A practical approach to the diagnosis of pelvic inflammatory disease.

Authors:  Oluwatosin Jaiyeoba; David E Soper
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-26

7.  Detection of pelvic inflammatory disease: development of an automated case-finding algorithm using administrative data.

Authors:  Catherine L Satterwhite; Onchee Yu; Marsha A Raebel; Stuart Berman; Penelope P Howards; Hillard Weinstock; David Kleinbaum; Delia Scholes
Journal:  Infect Dis Obstet Gynecol       Date:  2011-11-14

8.  Sensitive simultaneous detection of seven sexually transmitted agents in semen by multiplex-PCR and of HPV by single PCR.

Authors:  Fabrícia Gimenes; Fabiana Soares Medina; André Luelsdorf Pimenta de Abreu; Mary Mayumi Taguti Irie; Isis Baroni Esquiçati; Natália Malagutti; Vinícius Rodrigo Bulla Vasconcellos; Michele Garcia Discacciati; Marcelo Gialluisi Bonini; Silvya Stuchi Maria-Engler; Marcia Edilaine Lopes Consolaro
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

9.  Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model.

Authors:  Malcolm J Price; A E Ades; Daniela De Angelis; Nicky J Welton; John Macleod; Kate Soldan; Ian Simms; Katy Turner; Paddy J Horner
Journal:  Am J Epidemiol       Date:  2013-06-27       Impact factor: 4.897

Review 10.  Metabolite Profiling in the Pursuit of Biomarkers for IVF Outcome: The Case for Metabolomics Studies.

Authors:  C McRae; V Sharma; J Fisher
Journal:  Int J Reprod Med       Date:  2013-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.